search
Back to results

Elevation of the Fetal Buttocks Prior to External Cephalic Version

Primary Purpose

Breech Presentation, External Cephalic Version

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fetal Pillow insertion
Sponsored by
AdventHealth
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Breech Presentation focused on measuring Breech, Version

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. Women delivering at AdventHealth Orlando campus.
  2. Breech presenting part as diagnosed by bedside sonography.
  3. No prior deliveries >/= 20 weeks gestational age.
  4. Pregnancy is between 37-40 weeks gestational age.
  5. Live fetus.
  6. Patient is >/= age 18.
  7. Patient speaks English or Spanish as primary language.
  8. Patient able to understand verbal and written consent

Exclusion Criteria:

  1. Non-breech presentation (cephalic, transverse, oblique).
  2. More than 1 fetus.
  3. Cervical dilation of >/= 1cm.
  4. Prior uterine incision.
  5. Congenital uterine anomaly.
  6. Body mass index more than 40 kg/m2.
  7. Uterine fibroids causing soft tissue dystocia.
  8. Extended fetal neck.
  9. Oligohydramnios (4-quadrant amniotic fluid index </= 5cm).
  10. Spontaneous rupture of membranes.
  11. Any contraindication to vaginal delivery.
  12. Intrauterine growth restriction (estimated fetal weight </= 10%ile).
  13. Estimated fetal weight > /= 5,000 grams for non-diabetic patient or >/= 4,500 grams for patient with pre-existing or gestational diabetes, confirmed by ultrasound.
  14. Fetal gastroschisis.
  15. Fetal neural tube defect.
  16. Severe-range preeclampsia.
  17. Patient had regional anesthesia immediately prior to ECV.

Sites / Locations

  • AdventHealth Orlando

Arms of the Study

Arm 1

Arm 2

Arm Type

Sham Comparator

Experimental

Arm Label

Control

Intervention

Arm Description

Non-inflation of the balloon device

Inflation of the balloon device

Outcomes

Primary Outcome Measures

Successful external cephalic version
Successful conversion of breech fetus to cephalic presentation

Secondary Outcome Measures

Cesarean delivery
Presence of cesarean delivery
Fetal presentation at time of delivery
Presentation of the fetus during participant delivery
Cost of ECV procedure and hospital stay (mother)
Total cost of hospital stay for mother
Cost of ECV procedure and hospital stay (neonate)
Cost of neonate's hospitalization after delivery
Shoulder dystocia
Presence of shoulder dystocia during delivery
Rupture of membranes
Presence of rupture of membranes after ECV procedure
Emergency cesarean delivery
Need for emergency cesarean delivery during or after ECV procedure
Pelvic hematoma
Development of a pelvic hematoma within 1 hour of ECV procedure
Procedural pain
Visual analogue pain score prior to during and after ECV procedure (100mm visual analogue scale where 0 =no pain and 10=extreme pain).
Number of attempts
Number of attempted ECV procedures to convert fetus from breech to cephalic presentation
Cost of hospital stay for ECV procedure
Total cost of the hospital stay for the ECV procedure

Full Information

First Posted
August 17, 2020
Last Updated
February 1, 2023
Sponsor
AdventHealth
search

1. Study Identification

Unique Protocol Identification Number
NCT04538261
Brief Title
Elevation of the Fetal Buttocks Prior to External Cephalic Version
Official Title
Elevation of the Fetal Buttocks Prior to External Cephalic Version
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Terminated
Why Stopped
Not recruiting at the rate we thought it would.
Study Start Date
November 1, 2020 (Actual)
Primary Completion Date
January 31, 2023 (Actual)
Study Completion Date
January 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AdventHealth

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a prospective, randomized double-blind clinical trial evaluating the effect of a balloon device (Fetal Pillow) to elevate the fetal buttocks during external cephalic version procedures. Eligible study population: nulliparous pregnant women between 37-40 weeks estimated gestational age with a breech presenting fetus and no contraindications to external cephalic version.
Detailed Description
Patients meeting inclusion criteria will be offered participation in this study. After performing an obstetric sonogram to determine fetal position, amniotic fluid status, fetal weight and placental location, the patient will be randomized to either placement of the Fetal Pillow balloon device with sham inflation (control arm) or placement of the device with inflation (study arm). The researcher will show the patient the device, open the sterile container, and insert the device into the vagina per manufacturer's guidelines for all patients in the study. All patients will mark a line on a 100mm VAS to assess pre-insertion and post-insertion pain. The study physician will then obtain the assistance of a certified nurse midwife to inflate the device or perform a sham inflation. In order for the physician investigator to remain blinded, the physician will leave the room during the time of the inflation/sham inflation. A certified nurse midwife previously trained to inflate the device will perform the inflation or sham inflation per randomization. The assisting midwife will inflate the device with 180 mL of saline for those patients randomized to inflation. This will occur under a sheet so that the patient is blinded to the randomization scheme. If the patient is randomized to no inflation, the midwife will perform a sham inflation, also under a sheet. All patients will mark a line on a 100mm VAS to assess post-inflation/sham inflation pain. The assisting midwife then leaves the room, and the study physician reenters the room and proceeds with the external cephalic version (ECV) procedure. Regardless of randomization, at this point the ECV procedure proceeds using normal routine. The ECV will be attempted up to four times and VAS will be assessed after each attempt. Once completed, all patients will also mark a line on a 100mm VAS to assess post-ECV pain. The research physician will then remove the Fetal Pillow. Regardless of randomization, the procedure is completed per the usual routine of fetal monitoring, assessing for rupture of membranes, labor or bleeding, discussing post-procedure care, then discharge home (or, less likely, admitting for either observation or delivery). The researcher will fill out the ECV portion of the data collection form. Data are collected later for delivery outcomes and costs for the mother and neonate.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breech Presentation, External Cephalic Version
Keywords
Breech, Version

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized trial using control and interventional arms.
Masking
ParticipantCare ProviderInvestigator
Masking Description
Investigators and participants will not know whether participants have undergone inflation of the balloon device.
Allocation
Randomized
Enrollment
11 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Sham Comparator
Arm Description
Non-inflation of the balloon device
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Inflation of the balloon device
Intervention Type
Device
Intervention Name(s)
Fetal Pillow insertion
Intervention Description
Inflation of balloon device used to elevate fetal buttocks prior to performing external cephalic version procedure
Primary Outcome Measure Information:
Title
Successful external cephalic version
Description
Successful conversion of breech fetus to cephalic presentation
Time Frame
Immediately upon completion of the ECV procedure
Secondary Outcome Measure Information:
Title
Cesarean delivery
Description
Presence of cesarean delivery
Time Frame
Immediately after ECV procedure or during subsequent labor and delivery
Title
Fetal presentation at time of delivery
Description
Presentation of the fetus during participant delivery
Time Frame
Labor and Delivery (approximately 12 hours)
Title
Cost of ECV procedure and hospital stay (mother)
Description
Total cost of hospital stay for mother
Time Frame
ECV procedure and during labor, delivery, and immediate postpartum period (up to 42 days)
Title
Cost of ECV procedure and hospital stay (neonate)
Description
Cost of neonate's hospitalization after delivery
Time Frame
Birth to hospital discharge (up to 42 days)
Title
Shoulder dystocia
Description
Presence of shoulder dystocia during delivery
Time Frame
Labor and Delivery (approximately 12 hours)
Title
Rupture of membranes
Description
Presence of rupture of membranes after ECV procedure
Time Frame
Within 1 hour of ECV procedure
Title
Emergency cesarean delivery
Description
Need for emergency cesarean delivery during or after ECV procedure
Time Frame
During or within 1 hour of performing ECV procedure
Title
Pelvic hematoma
Description
Development of a pelvic hematoma within 1 hour of ECV procedure
Time Frame
During or within 1 hour of performing ECV procedure
Title
Procedural pain
Description
Visual analogue pain score prior to during and after ECV procedure (100mm visual analogue scale where 0 =no pain and 10=extreme pain).
Time Frame
Immediately before, during, and within 2 minutes after completing the ECV procedure
Title
Number of attempts
Description
Number of attempted ECV procedures to convert fetus from breech to cephalic presentation
Time Frame
During and immediately after ECV procedure
Title
Cost of hospital stay for ECV procedure
Description
Total cost of the hospital stay for the ECV procedure
Time Frame
Patient arrival to labor unit for ECV procedure and discharge home (up to 72 hours)

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women delivering at AdventHealth Orlando campus. Breech presenting part as diagnosed by bedside sonography. No prior deliveries >/= 20 weeks gestational age. Pregnancy is between 37-40 weeks gestational age. Live fetus. Patient is >/= age 18. Patient speaks English or Spanish as primary language. Patient able to understand verbal and written consent Exclusion Criteria: Non-breech presentation (cephalic, transverse, oblique). More than 1 fetus. Cervical dilation of >/= 1cm. Prior uterine incision. Congenital uterine anomaly. Body mass index more than 40 kg/m2. Uterine fibroids causing soft tissue dystocia. Extended fetal neck. Oligohydramnios (4-quadrant amniotic fluid index </= 5cm). Spontaneous rupture of membranes. Any contraindication to vaginal delivery. Intrauterine growth restriction (estimated fetal weight </= 10%ile). Estimated fetal weight > /= 5,000 grams for non-diabetic patient or >/= 4,500 grams for patient with pre-existing or gestational diabetes, confirmed by ultrasound. Fetal gastroschisis. Fetal neural tube defect. Severe-range preeclampsia. Patient had regional anesthesia immediately prior to ECV.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David A Hill, MD
Organizational Affiliation
AdventHealth
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ariana Mora
Organizational Affiliation
AdventHealth
Official's Role
Study Director
Facility Information:
Facility Name
AdventHealth Orlando
City
Orlando
State/Province
Florida
ZIP/Postal Code
32804
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
IPD will not be shared outside of research team.
Citations:
PubMed Identifier
32332415
Citation
External Cephalic Version: ACOG Practice Bulletin, Number 221. Obstet Gynecol. 2020 May;135(5):e203-e212. doi: 10.1097/AOG.0000000000003837.
Results Reference
background
PubMed Identifier
26868074
Citation
Seal SL, Dey A, Barman SC, Kamilya G, Mukherji J, Onwude JL. Randomized controlled trial of elevation of the fetal head with a fetal pillow during cesarean delivery at full cervical dilatation. Int J Gynaecol Obstet. 2016 May;133(2):178-82. doi: 10.1016/j.ijgo.2015.09.019. Epub 2016 Jan 15. Erratum In: Int J Gynaecol Obstet. 2023 Apr;161(1):333.
Results Reference
result
PubMed Identifier
25828903
Citation
Hofmeyr GJ, Kulier R, West HM. External cephalic version for breech presentation at term. Cochrane Database Syst Rev. 2015 Apr 1;2015(4):CD000083. doi: 10.1002/14651858.CD000083.pub3.
Results Reference
result
PubMed Identifier
18456227
Citation
Kok M, Cnossen J, Gravendeel L, van der Post J, Opmeer B, Mol BW. Clinical factors to predict the outcome of external cephalic version: a metaanalysis. Am J Obstet Gynecol. 2008 Dec;199(6):630.e1-7; discussion e1-5. doi: 10.1016/j.ajog.2008.03.008. Epub 2008 May 23.
Results Reference
result
PubMed Identifier
18055730
Citation
Weiniger CF, Ginosar Y, Elchalal U, Sharon E, Nokrian M, Ezra Y. External cephalic version for breech presentation with or without spinal analgesia in nulliparous women at term: a randomized controlled trial. Obstet Gynecol. 2007 Dec;110(6):1343-50. doi: 10.1097/01.AOG.0000295605.38175.7b.
Results Reference
result

Learn more about this trial

Elevation of the Fetal Buttocks Prior to External Cephalic Version

We'll reach out to this number within 24 hrs